Research Results on Jolly Good's Medical VR Will Be Presented for the First Time in the U.S. - Revealing Training VR for HALO Procedures at Large-Scale VR Seminar, SAEM2024

May 08, 2024 04:00 AM AEST | By Cision

Research Results on Jolly Good's Medical VR Will Be Presented for the First Time in the U.S. - Revealing Training VR for HALO Procedures at Large-Scale VR Seminar, SAEM2024 — Image source: Kalkine Media

Recent News

Westwater Resources Receives Letter of Interest from US EXIM Bank for...

Honeywell rises as BofA upgrades stock to Buy on a return to positive...

Improving Access to Care by Strengthening Local Health System Capacity

Cascale Emphasizes Role of Brand-Supplier Relationships To Achieve Sus...

BROOKLINE, Mass., May 8, 2024 /PRNewswire/ -- Jolly Good US Inc. is proud to announce the groundbreaking debut of research findings on its Medical Virtual Reality (VR) platform in the United States. This unveiling will take place at the annual meeting of the Society for Academic Emergency Medicine (SAEM24), where cutting-edge innovations in Virtual Reality will be showcased to a global audience.

Research Results on Jolly Good’s Medical VR Will Be Presented for the First Time in the U.S.

In collaboration with Harvard Medical School, Jolly Good has developed an immersive case in Virtual Reality, simulating a scenario where a team at a level 1 Trauma center responds to an acutely injured patient following an explosion at a chemical plant. This pioneering VR material is poised to revolutionize resident education, providing an unparalleled training experience.

The Centers for Disease Control and Prevention (CDC) has highlighted the scarcity of U.S. physicians equipped with experience in treating blast injuries. Through this collaboration, we invite healthcare professionals to join us in exploring Virtual Reality simulation as a high-fidelity training method. Attendees will have the unique opportunity to experience a Virtual Reality simulation crafted by the Harvard Affiliated Emergency Medicine Residency.

This content will be unveiled for the first time at the "Virtual Reality Trauma Simulation: New Frontiers in Simulation Technology" VR hands-on seminar at the SAEM conference. Alongside presentations on Jolly Good's research on VR in medical education, participants will wear VR goggles to experience a realistic medical scene, showcasing the potential of VR applications in medical training.

Discover Jolly Good at "SAEM2024"

Exhibition Schedule: Tuesday, May 14 to Thursday, May 16, 2024
Location: Sheraton Phoenix Downtown 340 North 3rd Street Phoenix, Arizona, 85004
Booth Number: 120

Join VR Seminar at "SAEM24"

Title: Virtual Reality Trauma Simulation: New Frontiers in Simulation Technology
Date & Time: Friday, May 17, 2024 at 10:00am to 10:50am (PDT)
Location: Encanto B: Second Level
Presenter: Benjamin Lin, Mass General Brigham, Harvard Medical School
RSVP here: https://forms.gle/hqXinuQ622uhPUJE7

"Virtual Reality creates an opportunity for an environment for deliberate practice. It provides a scope and scalability beyond traditional mannequin-based simulation."
Dr. Kimo Takayesu, MD
Harvard Affiliated Emergency Medicine Residency Medical Education Fellowship Director
MGH Department of Emergency Medicine Simulation Officer

Join Us as Development Partners

Jolly Good is actively seeking collaboration with effectiveness verification partners from diverse medical-related institutions to promote and validate the compatibility of medical VR with Apple Vision Pro. Additionally, we are inviting potential joint development partners to enhance the value of our immersive healthcare experience. For inquiries, please click here:

https://jollygoodinc.com/contact

About Jolly Good Inc.

Jolly Good, a distinguished medical technology company hailing from Japan, specializes in the development of high-precision VR solutions and innovative medical and welfare services powered by AI, which meticulously analyzes user behavior within VR environments. Establishing Jolly Good US Inc. in 2023 marked our commitment to global expansion and pioneering advancements in healthcare technology.

Currently, we are engaged in collaborative joint development endeavors with prestigious institutions such as Harvard University and Boston University in the United States, as well as Mahidol University in Thailand.

Our mission encompasses a broad spectrum of initiatives, ranging from advancing medical education to innovating treatments for mental illness and providing support for employment opportunities. To learn more about our initiatives and contributions to the advancement of healthcare, please visit us at https://jollygoodinc.com/

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.